Vision Loss News and Research

RSS

Innovative approach for creating a cytomegalovirus vaccine

Each year, about 40,000 children are born infected with human cytomegalovirus, or CMV, and about 8,000 of these children suffer permanent disabilities due to the virus - almost one an hour.

2 Aug 2006

Scientists slow vision loss with vitamin E, alpha-lipoic acid and other antioxidant chemicals

Scientists at Johns Hopkins have successfully blocked the advance of retinal degeneration in mice with a form of retinitis pigmentosa (RP) by treating them with vitamin E, alpha-lipoic acid and other antioxidant chemicals.

24 Jul 2006

Antioxidants may slow vision loss

21 Jul 2006

New drug restores sight in sufferers from AMD

A new drug with the capacity to reverse vision loss in some patients with age-related macular degeneration (AMD) has won approval from the Food and Drug Administration (FDA) in the U.S.

3 Jul 2006

New drug helps diabetics keep their sight

Trials of an experimental drug which helps slow down the loss of vision caused by diabetes have had very optimistic results.

12 Jun 2006

Dietary glycemic index and carbohydrate in relation to early age-related macular degeneration

Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults and a person's risk may partly depend upon diet.

6 Jun 2006

New MIT designed device allows visually challenged to access Internet

An MIT poet has developed a small, relatively inexpensive "seeing machine" that can allow people who are blind, or visually challenged like her, to access the Internet, view the face of a friend, "previsit" unfamiliar buildings and more.

1 Jun 2006

Bladeless LASIK as good as standard microkeratome LASIK

A Mayo Clinic study comparing femtosecond (bladeless) and mechanical microkeratome LASIK surgeries has found equal results from both types six months post-surgery, using a variety of vision and eye health measurements.

3 May 2006

Extensive study of natalizumab

Scientists have completed an extensive study of more than 3,000 patients who received a promising anti-inflammatory drug, natalizumab, that was linked to three cases of a serious brain infection in large clinical trials halted in early 2005.

7 Mar 2006

Researcher identifies key to macular degeneration progression

Dr. Jayakrishna Ambati UK HealthCare physician and Associate Professor and Vice Chair of the Department of Ophthalmology and Visual Sciences, announced a discovery by his research team that will impact how physicians and patients approach treatment for macular degeneration.

7 Feb 2006

Retinal degeneration - researchers advance understanding

Researchers have labored for decades to understand blindness-inducing neurodegenerative diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP).

18 Jan 2006

Lazy eye might see bright future

Amblyopia, commonly known as lazy eye, is a developmental disorder of spatial vision in the absence of any detectable structural or pathologic abnormalities that cannot be corrected by refractive means. Prevalence estimates range from 1% to 5% depending on the population studied and the definition used.

10 Jan 2006

Study of 30-day extended wear contact lenses

A team of researchers led by the Johns Hopkins Wilmer Eye Institute have determined that the corneal infection rate associated with the use of 30-day -extended-wear contact lenses made from silicone hydrogel is comparable to that previously reported for older lens types worn for fewer consecutive 24-hour periods.

5 Dec 2005

Chlamydia pneumoniae may cause vision problems

Researchers at the Massachusetts Eye and Ear Infirmary (MEEI) have found that Chlamydia pneumoniae, a bacterium linked to heart disease and capable of causing chronic inflammation, was present in the diseased eye tissue of five out of nine people with neovascular, or "wet," age-related macular degeneration (AMD).

7 Nov 2005